AstraZeneca PLC (AZN)
166.80
+0.82
(+0.49%)
USD |
NYSE |
Aug 24, 16:00
166.71
-0.09
(-0.05%)
After-Hours: 20:00
AstraZeneca EPS Diluted (Quarterly) : 0.9849 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.9849 |
| December 31, 2025 | 0.743 |
| September 30, 2025 | 0.8063 |
| June 30, 2025 | 0.7955 |
| March 31, 2025 | 0.934 |
| December 31, 2024 | 0.4757 |
| September 30, 2024 | 0.4574 |
| June 30, 2024 | 0.6176 |
| March 31, 2024 | 0.6984 |
| December 31, 2023 | 0.3075 |
| September 30, 2023 | 0.4404 |
| June 30, 2023 | 0.5827 |
| March 31, 2023 | 0.5779 |
| December 31, 2022 | 0.29 |
| September 30, 2022 | 0.526 |
| June 30, 2022 | 0.1154 |
| March 31, 2022 | 0.1236 |
| December 31, 2021 | -0.1122 |
| September 30, 2021 | -0.5521 |
| June 30, 2021 | 0.2086 |
| March 31, 2021 | 0.5917 |
| December 31, 2020 | 0.3854 |
| September 30, 2020 | 0.2468 |
| June 30, 2020 | 0.2879 |
| March 31, 2020 | 0.297 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.1193 |
| September 30, 2019 | 0.1139 |
| June 30, 2019 | 0.0495 |
| March 31, 2019 | 0.2338 |
| December 31, 2018 | 0.408 |
| September 30, 2018 | 0.1701 |
| June 30, 2018 | 0.1381 |
| March 31, 2018 | 0.1351 |
| December 31, 2017 | 0.515 |
| September 30, 2017 | 0.27 |
| June 30, 2017 | 0.19 |
| March 31, 2017 | 0.21 |
| December 31, 2016 | 0.725 |
| September 30, 2016 | 0.3998 |
| June 30, 2016 | -0.0012 |
| March 31, 2016 | 0.2525 |
| December 31, 2015 | 0.3194 |
| September 30, 2015 | 0.3043 |
| June 30, 2015 | 0.275 |
| March 31, 2015 | 0.2174 |
| December 31, 2014 | -0.1244 |
| September 30, 2014 | 0.0993 |
| June 30, 2014 | 0.3166 |
| March 31, 2014 | 0.2009 |
| December 31, 2013 | -0.2164 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GSK Plc | 0.2875 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
| Merck & Co., Inc. | -0.5405 |
| Novo Nordisk A/S | 0.7362 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.076B |
| Revenue (Quarterly) | 15.26B |
| Total Expenses (Quarterly) | 12.19B |
| Enterprise Value | 541.11B |
| Gross Profit Margin (Quarterly) | 76.09% |
| Profit Margin (Quarterly) | 20.15% |
| Earnings Yield | 2.00% |
| Operating Earnings Yield | 2.70% |
| Normalized Earnings Yield | 2.020 |